Penserra Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Penserra Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,619	Closed	-$412K	–	839
2020 Q1	$412K	Buy	+2,619	New	+$373K	0.03%	356
2018 Q4	–	Sell	-15,440	Closed	-$2.45M	–	675
2018 Q3	$2.45M	Buy	+15,440	New	+$2.34M	0.15%	92

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Penserra Capital Management's FBT Position: Q2 2020 in Review

Penserra Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2020, closing a stake of 2,619 shares — an estimated $412K sold.

Penserra Capital Management first reported a position in FBT in Q3 2018 and held it in 2 quarters. The position peaked at $2.45M in Q3 2018. 224 funds tracked by Wall St. Rank hold FBT as of Q2 2020.

Penserra Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2020 after selling out during the quarter.
Penserra Capital Management sold 2,619 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2020, an estimated $412K.
Penserra Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 2 quarters.
Penserra Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.45M in Q3 2018.
224 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2020.

Based on Penserra Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.